RO7812653

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO7812653, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD) [Phase 1]

See pricing